Evidence map›Paper›PMID 38987181›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Necrotizing Fasciitis Due to Group A Streptococcus: A Case of a Deteriorating Biphasic-like Clinical Course over Five Days with a Devastating Outcome.

Kenya Toma, Haruka Ishiki, Yusuke Oshiro, Takashi Shinzato, Yasuharu Tokuda

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kenya TomaDivision of Infectious Diseases and General Internal Medicine, Nakagami General Hospital, Japan.
Haruka IshikiDivision of Infectious Diseases and General Internal Medicine, Nakagami General Hospital, Japan.
Yusuke OshiroDivision of Infectious Diseases and General Internal Medicine, Nakagami General Hospital, Japan.
Takashi ShinzatoDivision of Infectious Diseases and General Internal Medicine, Nakagami General Hospital, Japan.
Yasuharu TokudaDivision of Infectious Diseases and General Internal Medicine, Nakagami General Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Necrotizing fasciitis (NF) is a life-threatening disease with high mortality and rapidly progressive clinical manifestations. Early detection and surgical management coupled with antibiotic treatment are crucial for the survival, and the patient survival is heavily dependent on clinical decisions. However, it is not widely known that NF does not always follow a typical clinical course, and there have been no case reports of NF following an atypical clinical course. Although the course of the disease depends on the individual patient, it remains a challenge for physicians to determine the precise timing when patients are most likely to survive multiple surgical interventions. We encountered a challenging case presenting with an atypical clinical course. We herein report a 31 year-old man who followed a deteriorating biphasic-like clinical course and presented with extensive NF and streptococcal toxic shock syndrome due to Group A Streptococcus. This case serves to inform physicians of the existence of NF with an atypical and deteriorating biphasic-like clinical course, emphasizing the need for a careful evaluation of the patient condition.

Indexed as

Clinical DeteriorationFasciitis, NecrotizingShock, SepticStreptococcal InfectionsStreptococcus pyogenesAdultAnti-Bacterial AgentsFatal OutcomeHumansMaleTime FactorsAnti-Bacterial Agentsantibiotic treatment and surgical managementGroup A Streptococcusnecrotizing fasciitis

Identifiers

PMID38987181
PMCPMC11949674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.